Scinovex
articleTop 1% cited

CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages

Acta Psychiatrica Scandinavica · 2001 · Vol. 104(3) · pp. 173–192
Julia KirchheinerKim BrøsenMarja­‐Liisa DahlL. F. GramSiegfried KasperIvar RootsFolke SjöqvistEdoardo SpinaJ. Brockmöller

Abstract

We have provided preliminary average dose suggestions based on the phenotype or genotype. This is a first attempt to apply the new pharmacogenetics to suggest dose-regimens that take the differences in drug metabolic capacity into account.

Pharmacogenetics and Drug MetabolismTreatment of Major DepressionCancer Treatment and PharmacologyCYP2D6CYP2C19PharmacogeneticsPharmacologyDoseMedicineTricyclicDrugPharmacokineticsTherapeutic drug monitoring

MeSH terms

Antidepressive AgentsAryl Hydrocarbon HydroxylasesCytochrome P-450 Enzyme SystemDepressive DisorderDose-Response Relationship, DrugFemaleGenotypeHumansMixed Function OxygenasesMalePhenotypePolymorphism, GeneticDrug MonitoringCytochrome P-450 CYP2D6Cytochrome P-450 CYP2C19
Citations
422
FWCI
25.46
field-weighted impact
References
192
Percentile
100%
vs. same field & year
Citations per year
References
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
British Journal of Clinical Pharmacology · 1998 · 844 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.